Second Federal Trial Over Vioxx Begins

Law360, New York (August 1, 2006, 12:00 AM EDT) -- In the opening of the second federal trial over Vioxx, the attorney representing a former FBI agent told a jury Monday that Vioxx was behind his client’s heart attack and that drug maker Merck & Co. Inc. chose to disregard red flags concerning the safety of its lucrative arthritis medication.

The attorney for Gerald Barnett, 62, said in the U.S. District Court for the Eastern District of Louisiana that Barnett exercised regularly and minded his diet.

But Merck’s lawyer contended that Barnett was at risk for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.